Parabase Genomics logo — Pioneering the future of newborn genetic diagnostics with ra...

Parabase Genomics

Pioneering the future of newborn genetic diagnostics with rapid, comprehensive testing for over 500 genes within 10 days using a simple dried blood spot.

Founded 2009 Series B Total: $2.97M Biotechnology, Health Care

General Information

Company Name Parabase Genomics
Founded Year 2009
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Parabase Genomics. To contact Parabase Genomics, visit parabasegenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Parabase Genomics compare?

A PDF of Parabase Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Parabase Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Parabase Genomics

Parabase Genomics is a biotechnology startup pioneering the future of newborn genetic diagnostics with its NewbornDx™ test. Founded in 2009, the company is committed to improving the diagnosis and treatment of genetic disorders in newborns and children. The NewbornDx™ test offers rapid, comprehensive testing for over 500 genes within 10 days using a simple dried blood spot, enabling physicians to obtain an accurate molecular profile without the need to rely on severe phenotypes. The company received a $2.00M Series B investment on November 4, 2014, with Walnut Venture Associates and SXE Ventures participating as investors. Parabase Genomics operates within the Biotechnology and Health Care industries, aiming to make a significant impact in the field of genetic diagnostics for newborns.

Business keywords: Genetic diagnostics, Molecular diagnostics, NewbornDx, Newborn health, Genetic disorders, Neonatal testing, Diagnostic technology, Medical innovation, Clinical testing, Dried blood spot testing

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $2.00M 2
Walnut Venture Associates, SXE Ventures
04 Nov 2014
Grant Undisclosed -
01 Jan 2013
Seed Round $970.00K -
20 Jul 2012

Parabase Genomics Alternatives & Competitors

View All Alternatives
Parabase Genomics vs

Caring for a calm start

Venture round
4 employees
Biotechnology, Health Care
Parabase Genomics vs

使命宣言: •为我们的民众提供高品质的,临床合理的综合诊断和咨询服务,通过个性化诊断实现精准医学。...

Series B
27 employees
Biotechnology, Care Economy
Parabase Genomics vs
Truvian
Truvian United States

blood testing anyone. anywhere.

Venture round
108 employees
Biotechnology, Health Care

FAQ About Parabase Genomics

Pioneering the future of newborn genetic diagnostics with rapid, comprehensive testing for over 500 genes within 10 days using a simple dried blood spot.
Parabase Genomics was founded in 2009.
Parabase Genomics operates in Biotechnology and Health Care. Its work centres on Genetic diagnostics, Molecular diagnostics, NewbornDx and Newborn health.
Parabase Genomics has completed 3 funding rounds, raising a total of $2.97M. The latest funding stage is Series B.
Top alternatives and competitors to Parabase Genomics include Calmark Sweden AB, 广州嘉检医学检测有限公司, Truvian, CellScape, HNL Lab Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Parabase Genomics and Calmark Sweden AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Parabase Genomics, https://bouncewatch.com/company/parabase-genomics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes